PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 22 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,000 | +700.0% | 1,000 | +233.3% | 0.00% | – |
| Q2 2020 | $1,000 | – | 300 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $396,000 | 0.12% |
| Sofinnova Investments, Inc. | 142,635 | $482,000 | 0.04% |
| INSPIRION WEALTH ADVISORS, LLC | 22,075 | $75,000 | 0.03% |
| Iron Gate Global Advisors LLC | 14,641 | $49,000 | 0.03% |
| REGENTATLANTIC CAPITAL LLC | 18,245 | $62,000 | 0.00% |
| Ellis Investment Partners, LLC | 3,250 | $10,000 | 0.00% |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 45 | $0 | 0.00% |
| Renaissance Technologies | 91,569 | $309,000 | 0.00% |
| BARCLAYS PLC | 1 | $0 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,678 | $46,000 | 0.00% |